Repository logo
Communities & Collections
All of DSpace
  • English
  • العربية
  • বাংলা
  • Català
  • Čeština
  • Deutsch
  • Ελληνικά
  • Español
  • Suomi
  • Français
  • Gàidhlig
  • हिंदी
  • Magyar
  • Italiano
  • Қазақ
  • Latviešu
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Srpski (lat)
  • Српски
  • Svenska
  • Türkçe
  • Yкраї́нська
  • Tiếng Việt
Log In
New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Shima, F. K."

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Results Per Page
  • Sort Options
  • Thumbnail Image
    Item
    Evaluation of amoxicillin content in commonly used multisource Injectable brands in veterinary practice
    (Egypt’s Presidential Specialized Council for Education and Scientific Research, 2019) Gberindyer, A .F.; Olaogun, S. C.; Omotosho, O. O.; Adedokun, R. A. M.; Shima, F. K.
    THE AIM Is To Evaluate Amount Of Amoxicillin In The Array Of Its Injectable Formulations From Multisource Marketed And Commonly Used In Veterinary Practice In Nigeria. The Amount Of Amoxicillin In Each Of The 10 Brands Sampled Was Analysed Using A High-Performance Liquid Chromatography. Thereafter, Percentages Of The Labelled Amount Of Amoxicillin Were Determined And Compared With 90-120% Specified In USP And IP. Samples G, H, And J Contained 93%, 98%, And 108%, Respectively Of The Labeled Amount Of Amoxicillin, While B, C, And A Contained Only 39%, 56%, And 58%, Respectively. Again, Samples I, F, D, And E Contained 124%, 135%, 147%, And 413%, Respectively Of The Labelled Amount. Thus, Only Brands G, H, And J Passed Assay Quality Test (AQT) Since The Amount Of Amoxicillin They Contained Was Within The Specified USP And IP Range, And Are Considered Pharmaceutically Equivalent, Consequently, Interchangeable For Intravenous Administrations. Whereas, Brands A, B, And C Failed AQT Because They Contained Less Than The Amount Of Amoxicillin Required, So Even When Used Prudently There Could Be Therapeutic Failure, Bacterial Resistance, And Public Health Implications. Similarly, Brands D, E, F, And I Could Cause Toxicity And High Tissue Residues Because They Contained Higher Than The Required And Labelled Amount Of Amoxicillin. About 30% And 40% Of The Analysed Amoxicillin Brands Contained Less And More Than The Required Amount Of Amoxicillin, Respectively. However, 30% Contained The Amount Within The Specified Range. Consequently, There Is High Rate Of Substandard Amoxicillin Injectable Brands For Veterinary Use In Nigeria Hence The Need For Regular Monitoring.

DSpace software copyright © 2002-2026 Customised by Abba and King Systems LLC

  • Privacy policy
  • End User Agreement
  • Send Feedback
Repository logo COAR Notify